NewsBite

Replica Ozempic and Mounjaro will be banned by October

Nick Bonyhady
Nick BonyhadyTechnology writer

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Tens of thousands of Australians will be kicked off their weight loss medication in October after the government decided to ban chemists from replicating the blockbuster drugs Ozempic and Mounjaro on safety grounds.

The ruling is a major blow to the online health start-up Eucalyptus and insurer NIB’s Midnight Health, which are two of the largest prescribers of the medication, alongside individual general practitioners.

Loading...
Nick Bonyhady is a technology writer for the Australian Financial Review, based in Sydney. He is a former technology editor, industrial relations and politics reporter at the Sydney Morning Herald and Age. Connect with Nick on Twitter. Email Nick at nick.bonyhady@afr.com

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More

Latest In Technology

Fetching latest articles

Most Viewed In Technology

    Original URL: https://www.afr.com/technology/replica-ozempic-and-mounjaro-will-be-banned-by-october-20240521-p5jfgh